Home / Share Price Target / Ortinlab
Ortin Laboratories Share Price Target 2024, 2025, 2026 to 2039 With Charts
Ortin Laboratories Limited | |||
 | Symbol: ORTINLAB | ||
| Price: ₹22.74 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Ortin Laboratories Brief Company Overview
- 1.1: Ortin Laboratories: A Leading Pharma Powerhouse
- 1.2: Ortin Laboratories Financial Performance
- 1.2.1: Is Ortin Laboratories A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Ortin Laboratories Share Price Target For 2024
- 2.1.1: Ortin Laboratories Share Price Target Table For 2024
- 2.1.2: Summary: Ortin Laboratories Share Price Prediction For 2024
- 2.2: Ortin Laboratories Share Price Target For 2025
- 2.2.1: Ortin Laboratories Share Price Target Table For 2025
- 2.2.2: Summary: Ortin Laboratories Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Ortin Laboratories Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Ortin Laboratories Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Ortin Laboratories Past Performance
Ortin Laboratories Brief Company Overview
Ortin Laboratories: A Leading Pharma Powerhouse
Established in 1986, Ortin Laboratories has emerged as a prominent player in India's pharmaceutical industry. Headquartered in Hyderabad, the company engages in manufacturing and trading a diverse range of pharmaceuticals, drugs, and intermediates.
Known for its commitment to quality and innovation, Ortin Laboratories has garnered a solid reputation in the industry. Their products and services cater to a wide range of healthcare needs, including anti-diabetics, anti-allergics, antibiotics, and cardiovascular medications.
Ortin Laboratories' extensive product portfolio encompasses various formulations such as tablets, capsules, syrups, and powders. They also offer active pharmaceutical ingredients (APIs), fine chemicals, and grignard and alkali metal products.
Beyond manufacturing, Ortin Laboratories provides specialized services in process development, analytical research, assay development, and diagnostics. They also undertake long-term contracts for manufacturing intermediates and developing new APIs, demonstrating their commitment to innovation and growth.
Advertisement
Ortin Laboratories Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 16.82 Crore | Market valuation of Ortin Laboratories's shares. |
| Revenue (TTM) | 2.11 Crore | Total revenue generated by Ortin Laboratories over the past twelve months. |
| Net Income (TTM) | -8.04 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -2255.67% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 43.69% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -90.1% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio | 63.82 | Company's total debt divided by total shareholder equity. |
| Total Debt | 1.8 Crore | Sum of Ortin Laboratories's current & long-term financial obligations. |
| Total Cash | 2.34 Crore | Total amount of liquid funds available to Ortin Laboratories. |
| Beta | 1.36 | Beta is greater than 1 indicating that the Ortin Laboratories's price is more volatile than the market. |
Is Ortin Laboratories A Good Buy For Long Term?
Ortin Laboratories, with a market cap of 17.09 Crore, is a small-cap stock facing significant challenges. While a 2.34 Crore cash balance is positive, the company has a -8.04 Crore net profit for the last 12 months and a concerning -90.1% decline in revenue compared to the previous quarter. Adding to these concerns, the company holds 1.8 Crore in debt. Given these factors, including a -66.13% return over the past three years, Ortin Laboratories is not a good buy for long-term investment.
To predict the Ortin Laboratories's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Ortin Laboratories Share Price Target For 2024
The line chart displays the monthly closing prices of Ortin Laboratories with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Ortin Laboratories shares in 2024, see the table below.
Advertisement
Ortin Laboratories Share Price Target Table For 2024
| Ortin Laboratories's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 23.78 (+4.57%) | Fibonacci Extension Level 100% |
| 2024 Target 2 | 23.46 (+3.16%) | Price Action: Aug 2015 Low |
| 2024 Target 1 | 23.15 (+1.8%) | Price Action: Aug 2014 Low |
| Current Price | 22.74 | Ortin Laboratories's 1 share price as of Fri 06 Sep 2024 |
| Stop Loss 1 | 22.52 (-0.97%) | Fibonacci Retracement Level 50% |
| Stop Loss 2 | 22.21 (-2.34%) | Price Action: Aug 2013 Low |
| Stop Loss 3 | 21.98 (-3.35%) | Price Action: Jun 2020 Low |
Summary: Ortin Laboratories Share Price Prediction For 2024
In summary, Ortin Laboratories has declined by ₹-0.36, recording a notable -1.56% decrease from 1st January 2024 to 06 Sep 2024. Despite the setback, our analysis of Ortin Laboratories for 2024 predicts an additional rise of 1.8% to 4.57% by the end of 2024 with three potential targets T1: 23.15, T2: 23.46, T3: 23.78. Stop Loss at SL1: 22.52, SL2: 22.21, SL3: 21.98.
Ortin Laboratories has a 52-week high of ₹26.35, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹16.20, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Ortin Laboratories.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Ortin Laboratories Share Price Target For 2025
The line chart displays the monthly closing prices of Ortin Laboratories with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Ortin Laboratories shares in 2025, see the table below.
Advertisement
Ortin Laboratories Share Price Target Table For 2025
| Ortin Laboratories's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 30.18 (+32.71%) | Price Action: Chart |
| 2025 Target 2 | 29.62 (+30.25%) | Price Action: Chart |
| 2025 Target 1 | 29.33 (+28.97%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 22.74 | Ortin Laboratories's 1 share price as of Fri 06 Sep 2024 |
| Stop Loss 1 | 21.10 (-7.22%) | Price Action: Dec 2007 High |
| Stop Loss 2 | 20.85 (-8.32%) | Price Action: Jul 2022 Low |
| Stop Loss 3 | 20.62 (-9.33%) | Price Action: Feb 2020 High |
Summary: Ortin Laboratories Share Price Prediction For 2025
In summary, Ortin Laboratories has declined by ₹-0.36, recording a notable -1.56% decrease from 1st January 2024 to 06 Sep 2024. Despite the setback, our analysis of Ortin Laboratories for 2025 predicts an additional rise of 28.97% to 32.71% by the end of 2025 with three potential targets T1: 29.33, T2: 29.62, T3: 30.18. Stop Loss at SL1: 21.10, SL2: 20.85, SL3: 20.62.
Ortin Laboratories has a All-Time high of ₹87.91, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹16.20, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Ortin Laboratories, we have created a specific page for that check here: Ortin Laboratories Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Ortin Laboratories Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Ortin Laboratories share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 4.3% over the next 15 years.
For complete year by year Ortin Laboratories long term share price target from 2024, 2025 to 2039 check the below table.
Ortin Laboratories Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Ortin Laboratories Target | YoY Change % |
|---|---|---|
| 2024 | ₹22.74 | [Current Price] |
| 2024 | ₹18.57 | -18.3% |
| 2025 | ₹22.66 | 21.95% |
| 2026 | ₹23.57 | 4.01% |
| 2027 | ₹23.36 | -0.9% |
| 2028 | ₹21.25 | -9.04% |
| 2029 | ₹21.93 | 3.19% |
| 2030 | ₹26.59 | 21.24% |
| 2031 | ₹27.52 | 3.49% |
| 2032 | ₹27.16 | -1.31% |
| 2033 | ₹24.59 | -9.47% |
| 2034 | ₹25.27 | 2.76% |
| 2035 | ₹30.53 | 20.81% |
| 2036 | ₹31.48 | 3.11% |
| 2037 | ₹30.96 | -1.66% |
| 2038 | ₹27.93 | -9.79% |
| 2039 | ₹33.47 | 19.87% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Ortin Laboratories Past Performance
- In 2007, Ortin Laboratories opening price was ₹18.55
- As of Fri 06 Sep 2024 the price stands at ₹22.74.
- This represents a Compound Annual Growth Rate (CAGR) of 1.14%.
- In 17 years, an investment of 10,000 would have become ₹12,258.76.
As we wrap up, we hope you like our study on Ortin Laboratories share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
